Anne Sieben Selected Research

Synucleins

12/2021

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne Sieben Research Topics

Disease

12	Alzheimer Disease (Alzheimer's Disease) 11/2022 - 12/2015
6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2018 - 09/2012
5	Dementia (Dementias) 05/2022 - 07/2017
5	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 11/2015
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 11/2015
2	Primary Progressive Aphasia 01/2022 - 12/2018
2	Parkinson Disease (Parkinson's Disease) 12/2021 - 01/2017
2	Proteostasis Deficiencies 01/2018 - 09/2012
1	Amyloid Plaque 11/2022
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2021
1	Lewy Body Disease (Lewy Body Dementia) 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Death (Near-Death Experience) 01/2019
1	Chromosome Inversion (Chromosomal Inversion) 01/2019
1	Tauopathies 12/2018
1	Broca Aphasia (Expressive Aphasia) 12/2018
1	Atrophy 01/2018
1	Cognitive Dysfunction 01/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2016
1	Neurobehavioral Manifestations 01/2016
1	Disease Susceptibility (Diathesis) 09/2014
1	Sarcoma (Soft Tissue Sarcoma) 09/2012
1	Neoplasms (Cancer) 03/2012
1	Atherosclerosis 03/2012
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 09/2009
1	Glioblastoma (Glioblastoma Multiforme) 05/2007
1	Multiple System Atrophy 04/2006

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 11/2022 - 09/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2012
4	Amyloid (Amyloid Fibrils)IBA 11/2022 - 01/2018
4	DNA-Binding Proteins (DNA Binding Protein)IBA 12/2018 - 09/2012
2	Peptides (Polypeptides)IBA 11/2022 - 11/2020
2	Biological ProductsIBA 05/2022 - 09/2012
2	ProgranulinsIBA 01/2018 - 11/2015
1	Threonine (L-Threonine)FDA Link 11/2022
1	tau Proteins (tau Protein)IBA 11/2022
1	Amino Acids FDA Link 11/2022
1	SynucleinsIBA 12/2021
1	NeurograninIBA 12/2021
1	PresenilinsIBA 11/2020
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2019
1	THK5351IBA 12/2018
1	Amyloid beta-PeptidesIBA 01/2018
1	sortilinIBA 01/2018
1	GranulinsIBA 01/2018
1	Neurofilament ProteinsIBA 01/2018
1	EpitopesIBA 07/2017
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2016
1	UbiquitinIBA 01/2016
1	Cystatin CIBA 01/2016
1	FilaminsIBA 11/2015
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 09/2012
1	hyperosideIBA 05/2007
1	hyperforinIBA 05/2007
1	Antidepressive Agents (Antidepressants)IBA 05/2007
1	Desipramine (Pertofrane)FDA LinkGeneric 05/2007

Therapy/Procedure

1	Therapeutics 01/2022
1	Euthanasia (Mercy Killing) 01/2019
1	Palliative Care (Palliative Therapy) 01/2019
1	Radiotherapy 03/2012
1	Transcranial Magnetic Stimulation 09/2009
1	Deep Brain Stimulation 04/2006